<DOC>
	<DOC>NCT00082511</DOC>
	<brief_summary>Open label safety and efficacy follow-up.</brief_summary>
	<brief_title>GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids</brief_title>
	<detailed_description>This was a randomized, multi-center, open-label, parallel-group, trial of prasterone 200 or 100 mg/day for 12 months in women with lupus receiving glucocorticoid therapy who had completed an earlier 6-month randomized, placebo-controlled study (NCT00053560. Bone Mineral Density assessments were performed at baseline and at months 6 and 12.</detailed_description>
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Patient has completed the full 6 month treatment period with study drug in the previous Genelabs' clinical study GL0201. Concomitant treatment with prednisone (or equivalent) at a dose of ≥ 5mg/day. Patient has read and signed an Informed Consent Form. If the patient is not fluent in English, the Informed Consent must be signed in her native language. Patient has had a serious study drug related adverse reaction at any time during the previous GL0201 study. Any condition which in the Investigator's or Sponsor's opinion is sufficient to prevent adequate compliance with the study or likely to confuse followup evaluation (e.g., alcoholism, drug addiction, acute withdrawal from chemical dependency, psychiatric disease). MEDICATIONS PROHIBITED AT ANY TIME DURING THE STUDY Calcitonin Bisphosphonates Fluoride at pharmacologic dose Strontium at pharmacologic dose Estrogenic steroids (except oral contraceptives) Selective Estrogen Receptor Modulator (raloxifene) Parathyroid hormone Any androgens, including prescription or nutritional supplement DHEA, other than study drug Additional Calcium supplements other than those prescribed as part of this study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Lupus</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>SLE</keyword>
	<keyword>Bone Loss</keyword>
	<keyword>DHEA</keyword>
</DOC>